Raymond James & Associates’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $201K | Buy |
|
|||||
|
2024
Q2 | $150K | Buy |
|
|||||
|
2024
Q1 | $325K | Buy |
|
|||||
|
2023
Q4 | $661K | Buy |
|
|||||
|
2023
Q3 | $459K | Sell |
|
|||||
|
2023
Q2 | $981K | Sell |
|
|||||
|
2023
Q1 | $908K | Sell |
|
|||||
|
2022
Q4 | $699K | Sell |
|
|||||
|
2022
Q3 | $552K | Buy |
|
|||||
|
2022
Q2 | $414K | Sell |
|
|||||
|
2022
Q1 | $1.02M | Buy |
|
|||||
|
2021
Q4 | $2.27M | Sell |
|
|||||
|
2021
Q3 | $3.4M | Buy |
|
|||||
|
2021
Q2 | $4.54M | Sell |
|
|||||
|
2021
Q1 | $4.98M | Buy |
|
|||||
|
2020
Q4 | $2.67M | Sell |
|
|||||
|
2020
Q3 | $1.21M | Buy |
|
|||||
|
2020
Q2 | $167K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $62K | Hold |
|
|||||
|
2019
Q2 | $73K | Hold |
|
|||||
|
2019
Q1 | $87K | Buy |
|